SUMMARY
Recovery from neuromuscular block produced by vecuronium was studied in 50 patients using electromyography and the train-of-four technique. Twenty patients received neostigmine 2.5 mg, 10 when the initial response of the trainof-four was 50% of control and 10 when it was 10%. Neostigmine 5 mg was investigated in a similar manner and in 10 patients spontaneous recovery was studied. In all patients the time to 70% recovery of the initial response and of the train-of-four ratio was followed. Neostigmine significantly reduced the time to 70% recovery of both ratios with both degrees of block, but neostigmine 5.0 mg did not give a substantially more rapid recovery than 2.5 mg. No evidence of a neostigmine-induced block was encountered. Neostigmine 2.5 mg was rapidly effective in antagonizing vecuronium-induced block, even when initial recovery was only slight: there was no advantage in using neostigmine 5.0mg. neous recovery after vecuronium was followed; in a second group of 10, neostigmine 2.5 mg was given to antagonize neuromuscular block when the ratio of the first response to the train-of-four to control (A'/A) was 10 % and in the third group of 10, neostigmine 2.5 mg was given when A'/A had reached 50 %; similarly, in the fourth group of 10 patients neostigmine 5.0 mg (in two 2.5-mg doses given 2 min apart) was given to patients when recovery was 10% and in the fifth group of 10 it was given when recovery was 50 %. On every occasion the first dose of neostigmine was preceded by atropine 1.2 mg. A further dose of atropine 0.6 mg preceded a second dose of neostigmine.
Premedication was with promethazine 50 mg orally the night before operation, with or without diazepam 10 mg orally 3 h before the procedure, or with a combination of morphine 10 mg and cyclizine 50 mg (Cyclimorph) i.m. 1 h before the operation. The different types of premciication were randomly distributed between the five groups. Anaesthesia was induced with thiopentone, fentanyl and either droperidol or a small dose of midazolam, according to the preference of the anaesthetist. Each patient then breathed 70 % nitrous oxide and oxygen using a Magill breathing system without the addition of a volatile agent. Ventilation was assisted as necessary to maintain the end-tidal carbon dioxide tension between 4.75 and 5.25 kPa (Normocap; Datex).
A control trace of the EMG was obtained. ECG electrodes (Deva Medical) were placed over the ulnar nerve at the wrist to act as stimulating electrodes and recording electrodes were placed over the adductor pollicis brevis and the base of the index finger on the palm of the hand. A copper earth electrode was strapped on the wrist between the recording and stimulating electrodes. Single pulse stimuli of increasing voltage were delivered to the ulnar nerve until the maximum height of the compound muscle action potential (CMAP) was achieved. The voltage was then increased a further 25%to ensure supramaximal stimulation. Stimulation then proceeded with train-of-four supramaximal stimuli (0.2 ms; 2 Hz) at 12-s intervals and the resulting control train-of-four CMAP recorded (at least 10 responses being obtained). The height of the peak deflection of the CMAP was measured. After the control readings had been completed, vecuronium 100 ug kg" 1 was injected and intubation of the trachea carried out when clinically appropriate.
Recovery was monitored using both the ratio of the first twitch of the train to control (A'/A) and the ratio of the fourth twitch to the first (D'/A', the train-of-four ratio). The train was repeated at 1-min intervals until the administration of neostigmine was imminent, when the intervals were reduced to 12 s until the end of the study. In those patients allowed to recover spontaneously, the TOF was repeated at 12-s intervals from recovery of 10% A'/A until the end of the study. Increments of vecuronium 40 ug kg" 1 (up to a maximum of four) were given when the ratio A'/A had returned to 10%. However, no increments were given to those in whom recovery was spontaneous.
The times measured were the times until A'/A and D'/A' had attained 70% (the latter taking longer). As A'/A was always found to return to within 10% control, it was not deemed necessary to adjust for zero drift of the EMG. Zero times for the group which recovered spontaneously were taken as being when the A'/A were exactly 10 % and 50 %. When neostigmine 2.5 mg was given at either of the two degrees of block, zero time was taken when it was actually administered; when two doses of neostigmine were given, zero time was taken at the administration of the first dose.
In the group in which recovery was spontaneous, monitoring was continued until D'/A' had reached 70%. In patients who received neostigmine, monitoring was continued for at least 10 min after the agent had been given in the case of patients with a block of 50 % and, in those with 90 % block, at least 20 min or until 70 % recovery of the TOF ratio (D'/A') had been achieved and maintained for 10 min. When the study had been completed and neuromuscular monitoring discontinued, the patient was allowed to breathe 100% oxygen spontaneously through the trachea! tube until the airway was considered safe. The trachea was then extubated.
Statistical analysis of the differences between the means was carried out using Tukey's method.
RESULTS
Details of the age, weight and sex of the patients studied are given in table I. Table II shows the mean times to 70 % recovery of both A'/A and D'/A' for spontaneous recovery and for the two different doses of neostigmine. Statistical analysis shows that recovery in terms of both A'/A and D'/A' was significantly accelerated in each instance by the administration of neostigmine (P < 0.01). However, the analysis also shows that in each case the difference in recovery time between administering two doses of neostigmine rather than one dose was not significant.
Thus, the time for spontaneous recovery to A'/A 70 % from the greater degree of block (A'/A 10%) was 15.5 min, the train-of-four ratio (D'/A') taking 24.2 min to reach 70%. This compares with 3.9 min (A'/A) and 9.2 min (D'/A') following a single bolus of neostigmine 2.5 mg. Increasing the dose of neostigmine from 2.5 mg to 5 mg produced very similar recovery times of 3.4 min for A'/A and 5.6 min for D'/A'. The time for spontaneous recovery of A'/A to 70% from a lesser degree of block (A'/A 50%) was 4.9 min and of the train-of-four ratio (D'/A') was 6.9 min. Following a single dose of neostigmine 2.5 mg at 50 % A'/A, the duration of recovery of A'/A was significantly reduced, to 1.2 min. The recovery time of the train-of-four ratio to 70% (D'/A') was also significantly reduced, to 2.1 min. Administration of neostigmine 5 mg in this group produced recovery times of 1.1 min for A'/A and 1.5 min for D'/A'.
Not evident from table II is the fact that, in the group in which recovery was spontaneous (and to whom no increments were given), the times from the administration of vecuronium 100 mg kg" 1 to 70% recovery were A'/A 39.6 (12.2) min, and of D'/A' 54.4 (18.9) min (table III) . In addition, it was found that the administration of neostigmine, even when 5.0 mg was administered to those with the lesser degree of block, was always followed by an acceleration of recovery of both of the ratios studied. In every patient studied, both A'/A and D'/A' ratios continued to increase. Thus no evidence of fade was seen which could have been interpreted as evidence of neostigmine-induced blockade.
DISCUSSION
This study demonstrates the marked acceleration of recovery which may be achieved by the administration of neostigmine 2.5 mg. This acceleration was greatest when antagonism was undertaken at the greater degree of block (A'/A = 10%) when the time to 70 % recovery of the train-offour ratio was reduced from a mean of 24 min for spontaneous recovery to 9 min following neostigmine 2.5 mg, a train-of-four ratio of 70% being considered to be the point at which recovery from block was adequate and safe (Brand et al., 1977) . Although a larger dose of neostigmine administered to patients with this degree of block produced an even faster rate of recovery, the difference for D'/A' was only of the order of 3.5 min and was of neither statistical nor clinical significance.
The acceleration of recovery was considerably less when neostigmine was given when there was already 50 % recovery A'/A. At this time, neostigmine 2.5 mg reduced the recovery time of D'/A' from a mean of 7 min for spontaneous recovery to 2 min following the neostigmine. A second dose of neostigmine tended further to shorten recovery time, but again this was unimportant.
Every patient made a rapid and complete recovery. Payne, Hughes and Al Azawi (1980) showed, with tubocurarine, dimethyl tubocurarine and gallamine, that an increase in tetanic fade (at 50 Hz) could follow a second dose of neostigmine 2.5 mg,-an effect which was most marked during the administration of 2 % halothane. No parallel effect was demonstrated here but, of course, had halothane been used as an adjuvant to anaesthesia or tetanic stimulation used as the method of assessing neuromuscular blockade, or both, fade might have been demonstrated.
It appears from this study that a full clinical recovery from vecuronium-induced neuromuscular blockade can be achieved at a mean time of about 10 min after the administration of neostigmine, even when the degree of recovery at which neostigmine is injected is small and the dose of neostigmine only 2.5 mg. However, as with other non-depolarizing neuromuscular blocking agents, there is considerable individual patient variation in the rates of recovery. For example, in one patient in the study it took 19 min for recovery of D'/A' to 70% following neostigmine 2.5 mg injected when A'/A was 10%, compared with a mean time of 9 min. Similarly, a considerable scatter in the rates of spontaneous recovery was seen, one patient taking 84 min from the time of administration of the initial bolus dose of vecuronium to show recovery of the train-of-four ratio to 70%. This is some 30 min longer than the mean time of 54 min in the 10 patients studied. The scatter is similar to that reported by Fox, Keens and Utting (1987) for spontaneous recovery of atracurium-induced neuromuscular blockade. Driessen and co-workers (1985) have described dose-dependent potentiation of vecuronium by midazolam in the rat. Using very large doses (0.5 and 5 mg kg" 1 ), depression of twitch height by 17% and 34%, respectively, was observed once a steady state blockade of the twitch height had been induced by vecuronium. In our study, only six patients received midazolam and these were randomly distributed between the groups. The mean dose of midazolam was 0.06 mg kg" 1 , the maximum in one patient being O.lmgkg" 1 . Presupposing a response in man similar to that in the rat, any potentiation of block is likely to be small, and in any event, is unlikely greatly to influence measured time between specific percentage recoveries from neuromuscular blockade.
In ideal circumstances, during clinical anaesthesia neuromuscular function would be measured and recorded using either mechanical (strain gauge) or electromyographic techniques, but this is not usually possible. Merely using tactile or visual assessment of the train-of-four ratio is unreliable during recovery, when the degree of block depends on assessing fade (Viby-Mogensen et al., 1985) . In the absence of sophisticated monitoring of neuromuscular function, it is advisable always to antagonize the action of vecuronium unless anticholinesterases are contraindicated or the degree of recovery is almost complete. This is especially so since individual rates of recovery vary greatly. Neostigmine 2.5 mg produces rapid recovery from neuromuscular blockade produced by vecuronium; neostigmine 5.0 mg is unnecessary, at least if some degree of recovery is already apparent.
The current study was conducted using a design almost identical to that used by Fox, Keens and Utting (1987) in a study of atracurium; a comparison of the results obtained is, therefore, of some value. Once A'/A had reached 10%, recovery from vecuronium was considerably faster than from atracurium, whether or not neostigmine was given. However, taking the time from an initial dose to 70 % spontaneous recovery of the train-of-four ratio (when the patient can be considered clinically to be "safe") gives another interesting comparison (table III) . The times are 66 (12) min for atracurium and 54 (18.9) min for vecuronium. Unless the action of the drugs is terminated by neostigmine, neither can be considered to be short-acting and the difference between them in terms of duration of action is quite small. Once the first response to the trainof-four has re-appearcd, however, recovery from vecuronium is more rapid than with atracurium, and when all four responses have returned it is very much faster.
